SOURCE: HEALTH LIVE
Irish drugmaker Shire Pharmaceuticals has been ordered to pay a $56.5 million fine to settle claims that it exaggerated the benefits of several of its drugs, including Adderall XR and Vyvanse, both used to treat attention deficit hyperactivity disorder (ADHD).
According to a U.S. Department of Justice (DOJ) announcement, Shire made unsupported claims that Adderall XR would “normalize” children taking the drug, reducing their behavioral symptoms to the same level as kids without ADHD.
Shire also made other claims about Adderall XR without clinical data to back them up, including that the drug would improve academic performance, reduce unemployment, and prevent criminal behavior, the DOJ alleges.
No comments:
Post a Comment